We investigated the effects of DPP4 inhibition on plasma levels of glucose-dependent insulinotropic polypeptide ( GIP ) , glucagon-like peptide 1 ( GLP1 ) , incretin effect , glucose tolerance , gastrointestinal-mediated glucose disposal ( GIGD ) and gastric emptying in healthy subjects .